Cargando…

Effectiveness of a digital therapeutic as adjunct to treatment with medication in pediatric ADHD

STARS-Adjunct was a multicenter, open-label effectiveness study of AKL-T01, an app and video-game-based treatment for inattention, as an adjunct to pharmacotherapy in 8–14-year-old children with attention-deficit/hyperactivity disorder (ADHD) on stimulant medication (n = 130) or not on any ADHD medi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kollins, Scott H., Childress, Ann, Heusser, Andrew C., Lutz, Jacqueline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997870/ https://www.ncbi.nlm.nih.gov/pubmed/33772095 http://dx.doi.org/10.1038/s41746-021-00429-0

Ejemplares similares

Proof-of-concept study of an at-home, engaging, digital intervention for pediatric ADHD
por: Davis, Naomi O., et al.
Publicado: (2018)

Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day
por: Wigal, Sharon B, et al.
Publicado: (2010)

A critical appraisal of atomoxetine in the management of ADHD
por: Childress, Ann C
Publicado: (2015)

“I Use Weed for My ADHD”: A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD
por: Mitchell, John T., et al.
Publicado: (2016)

Yoga as an Adjunct Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
por: Srinivas, S., et al.
Publicado: (2023)

A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder
por: Wigal, Sharon B, et al.
Publicado: (2009)

Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting
por: Childress, Ann C., et al.
Publicado: (2017)

The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study
por: Childress, Ann C., et al.
Publicado: (2015)

Leveraging machine learning to examine engagement with a digital therapeutic
por: Heusser, Andrew C., et al.
Publicado: (2023)

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adult Laboratory Classroom Study of the Efficacy and Safety of PRC-063 (Extended-Release Methylphenidate) for the Treatment of ADHD
por: Childress, Ann, et al.
Publicado: (2021)

Health system utilization before age 1 among children later diagnosed with autism or ADHD
por: Engelhard, Matthew M., et al.
Publicado: (2020)

Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate
por: Weisler, Richard H, et al.
Publicado: (2013)

Association between Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms and obesity and hypertension in early adulthood: A population-based study
por: Fuemmeler, Bernard F., et al.
Publicado: (2010)

Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2020)

Enhancing neural markers of attention in children with ADHD using a digital therapeutic
por: Gallen, Courtney L., et al.
Publicado: (2021)

Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD
por: Lachaine, Jean, et al.
Publicado: (2016)

Motivation Deficit in ADHD is Associated with Dysfunction of the Dopamine Reward Pathway
por: Volkow, Nora D., et al.
Publicado: (2010)

Characteristics of ADHD Symptom Response/Remission in a Clinical Trial of Methylphenidate Extended Release
por: Weiss, Margaret, et al.
Publicado: (2019)

ADHD and Intellectual Disability: using ADHD medication
por: Courtenay, K., et al.
Publicado: (2022)

Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Preschool Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2020)

Large-scale genetic investigation reveals genetic liability to multiple complex traits influencing a higher risk of ADHD
por: García-Marín, Luis M., et al.
Publicado: (2021)

Analysis of Daily Sleep Diary Measures From Multilayer Extended-Release Methylphenidate (PRC-063) Studies in Children and Adults With ADHD
por: Cataldo, Marc, et al.
Publicado: (2022)

Efficacy and Safety of PRC-063, Extended-Release Multilayer Methylphenidate in Adults with ADHD Including 6-Month Open-Label Extension
por: Weiss, Margaret D., et al.
Publicado: (2020)

Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study
por: Wigal, Sharon B., et al.
Publicado: (2019)

Yoga as an Adjunctive Intervention to Medication-Assisted Treatment with Buprenorphine+Naloxone
por: Lander, Laura, et al.
Publicado: (2017)

Dapagliflozin: an effective adjunctive treatment in type 1 diabetes
por: Yadegarfar, Ghasem, et al.
Publicado: (2021)

Shared Care Models in the Treatment of Pediatric Attention-Deficit/Hyperactivity Disorder (ADHD): Are They Effective?
por: Sultan, Meshal A., et al.
Publicado: (2018)

It Is Time to REACT: Opportunities for Digital Mental Health Apps to Reduce Mental Health Disparities in Racially and Ethnically Minoritized Groups
por: Friis-Healy, Elsa A, et al.
Publicado: (2021)

Potential effectiveness of digital therapeutics specialized in executive functions as adjunctive treatment for clinical symptoms of attention-deficit/hyperactivity disorder: a feasibility study
por: Sun, Tai Hui, et al.
Publicado: (2023)

Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite
por: Bulfone, Tommaso C., et al.
Publicado: (2018)

Adult ADHD Medications and Their Cardiovascular Implications
por: Sinha, A., et al.
Publicado: (2016)

Psychopharmacology of ADHD in pediatrics: current advances and issues
por: Greydanus, Donald E, et al.
Publicado: (2009)

MT30 Learnings from DTC Launch of a Digital Therapeutic for ADHD in Response to the COVID-19 FDA Policy for Digital Health Devices for the Treatment of Psychiatric Disorders
por: Palko, L
Publicado: (2022)

European guidelines on managing adverse effects of medication for ADHD
por: Graham, J., et al.
Publicado: (2010)

Balancing access to ADHD medication
Publicado: (2023)

The Adjunctive Digital Breast Tomosynthesis in Diagnosis of Breast Cancer
por: Yang, Tsung-Lung, et al.
Publicado: (2013)

Evaluating Therapeutic Effects of ADHD Medication Objectively by Movement Quantification with a Video-Based Skeleton Analysis
por: Ouyang, Chen-Sen, et al.
Publicado: (2021)

A Personalized, Interactive, Cognitive Behavioral Therapy–Based Digital Therapeutic (MODIA) for Adjunctive Treatment of Opioid Use Disorder: Development Study
por: Meyer, Björn, et al.
Publicado: (2021)

Adjunctive therapeutic effects of micronutrient supplementation in inflammatory bowel disease
por: Wu, Yanrui, et al.
Publicado: (2023)

Immune Modulation as an Effective Adjunct Post-exposure Therapeutic for B. pseudomallei
por: Wilson, William J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5jb2g4o495irsjd4hmliq9m0d7